Article
Point-of-care genetic testing for personalisation of antiplatelet treatment (RAPID GENE): a prospective, randomised, proof-of-concept trial.
Lancet (London, England) - 5 May 2012
Roberts Jason D, Wells George A, Le May Michel R, Labinaz Marino, Glover Chris, Froeschl Michael, Dick Alexander, Marquis Jean-Francois, O'Brien Edward, Goncalves Sandro, Druce Irena, Stewart Alexandre, Gollob Michael H, So Derek Y F
Abstract excerpt
BACKGROUND: Prospective assessment of pharmacogenetic strategies has been limited by an inability to undertake bedside genetic testing. The CYP2C19*2 allele is a common genetic variant associated with increased rates of major adverse events in individuals given clopidogrel after percutaneous coronary intervention (PCI). We used a novel point-of-care genetic test to identify carriers of the CYP2C19*2 allele and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.